vimarsana.com

புற்றுநோய் ப்ரெவெந்ஶந் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Too many research papers just languish on the shelf These St Louis scientists want to put them in action

Too many research papers just languish on the shelf These St Louis scientists want to put them in action
stlmag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stlmag.com Daily Mail and Mail on Sunday newspapers.

April top 10 in GI: colorectal cancer, AGA guidance, IBD

April top 10 in GI: colorectal cancer, AGA guidance, IBD Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You ve successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Healio Gastroenterology presents the following report on the top peer-tested stories in April. These stories include preference of stool-based screening for colorectal cancer over colonoscopy, new AGA guidelines, the latest research on elimination diets in eosinophilic esophagitis and more.

Skin cancer: Common drug may be effective

Squamous cell carcinoma is the second most common skin cancer in the United States. In a recent study, researchers exposed mice to UVB radiation and treated them with drugs that target dopamine D2 receptors. The study showed a reduction of squamous cell carcinomas in the treated mice. While more research is necessary to confirm the findings, this is the first time a study has shown that activating dopamine receptors may help prevent squamous cell carcinoma. According to the Skin Cancer Foundation, squamous cell carcinoma is the second most common form of skin cancer in the U.S., behind basal cell carcinoma.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.